Branislava Miljković, PhD

Dr sc. Branislava Miljković

Position: redovni professor
Organizational unitDepartment of Pharmacokinetics and Clinical Pharmacy
Address: Vojvode Stepe 450, 11221 Belgrade, Serbia
Room: Section S, SP-20
Phone: +381 11 3951-382
Fax: +381 11 3972840


Branislava Miljković is a professor and head of the Department of Pharmacokinetics and Clinical Pharmacy at the Faculty of Pharmacy, University of Belgrade, where she graduated, completed her master's studies and defended her doctoral dissertation. She completed her postgraduate studies in Clinical Pharmacy at Robert Gordon University, Aberdeen, UK. She is the coordinator of postgraduate studies in Clinical Pharmacy and Pharmaceutical Care at the Faculty of Pharmacy, University of Belgrade.

Dr sc. Branislava Miljković is the President of the Pharmaceutical Associations of Serbia (SFUS), a member of the Scientific Committee of the European Association of Hospital Pharmacists (EAHP), a member of the Editorial Board for Pharmacotherapy Guide, a member of the Council of Europe's EDQM Working Group for Guidelines on Medication Review. She was the president of the working group for drafting the National Guidelines for the Use of Medicines in Breastfeeding, the author of the Guidelines for Pharmacists in Primary Health Care, a member of the working group for the preparation of the Resolution on Pharmaceutical Health Care, member of the Committee for Human Medicines Authorisation (ALIMS), member of the Committee for Human Medicines Authorisation of the Montenegrin Agency for Medicinal Products and Medical Devices (CALIMS).

Branislava Miljković is the author of the textbooks Pharmacokinetics and Clinical Pharmacy in Theory and Practice.

Professor Branislava Miljković is the award winner of the Recognition of the Pharmaceutical Chamber of Serbia for loyalty to the pharmaceutical profession, the Recognition of the Pharmaceutical Associations of Serbia for outstanding contribution to the work of the Association, the annual award of the Ministry of Science, Technology and Development of the Republic of Serbia, annual ECNP award for her contribution in the field of pharmacotherapy of mental disorders, ICN Galenika Award for master's thesis and doctoral dissertation in the field of medicine.

  • Topić Vučenović V, Rajkovača Z, Jelić D, Stanimirović D, Mikov M, Miljković B, Vučićević K. Population exposure-response model of 131I in patients with benign thyroid disease. Eur J Pharm Sci. 2021 Oct 1;165:105942. doi: 10.1016/j.ejps.2021.105942. Epub 2021 Jul 14.PMID: 34273482
  • Jovanović M, Vučićević K, Miljković B. Understanding variability in the pharmacokinetics of atypical antipsychotics - focus on clozapine, olanzapine and aripiprazole population models. Drug Metab Rev. 2020; 52(1):1-18.
  • Kovacevic T, Miljkovic B, Kovacevic P, Dragic S, Momcicevic D, Avram S, Jovanovic M, Vucicevic K. Population pharmacokinetic model of vancomycin based on therapeutic drug monitoring data in critically ill septic patients. J Crit Care. 2020; 55:116-121.
  • Kovačević M, Vezmar Kovačević S, Radovanović S, Stevanović P, Miljković B. Potential drug–drug interactions associated with clinical and laboratory findings at hospital admission. Int J Clin Pharm. 2020;42(1):150–157. doi: 10.1007/s11096-019-00951-y.
  • Miljković N, van Overbeeke E, Godman B, Kovačević M, Anastasi A, Bochenek T, Huys I, Miljković B. Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages. Front Med (Lausanne). 2020;7:407. doi: 10.3389/fmed.2020.00407
  • Miljković N, Godman B, van Overbeeke E, Kovačević M, Tsiakitzis K, Apatsidou A, Nikopoulou A, Yubero CG, Portillo Horcajada L, Stemer G, Kuruc-Poje D, De Rijdt T, Bochenek T, Huys I, Miljković B.Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals. Front Med (Lausanne). 2020 May 12;7:157. doi: 10.3389/fmed.2020.00157. eCollection 2020.PMID: 32478082
  • Milenković B, Šuljagić V., Perić A., Dragojević-Simić V., Tarabar O., Milanović M., Putić V., Tomić D., Miljković B., Vezmar Kovačević S. Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study. Eur J Hosp Pharm. 2021, ejhpharm-2020-002574; DOI: 10.1136/ejhpharm-2020-002574
  • Kovačević M, Ćulafić M, Vezmar Kovačević S, Borjanić S, Keleč B, Miljković B, Amidžić R. Telepharmacy service experience during the COVID-19 pandemic in the Republic of Srpska, Bosnia and Herzegovina. Health Soc Care Community. 2021;10.1111/hsc.13590. doi: 10.1111/hsc.13590.
  • Ćulafić M, Vezmar-Kovačević S, Dopsaj V, Oluić B, Bidžić N, Miljković B, Ćulafić Đ Pentoxifylline with metformin treatment improves biochemical parameters in patients with nonalcoholic steatohepatitis. .J Med Biochem. 2020 Sep 2;39(3):290-298. doi: 10.2478/jomb-2019-0043.PMID: 33269017
  • Ćulafić M, Vezmar Kovačević S, Dopsaj V, Štulić M, Vlaisavljević Z, Miljković B, Ćulafić D. A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests. Medicina (Kaunas). 2019 Jun 3;55(6):243. doi: 10.3390/medicina55060243.